These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7614704)

  • 1. DNA adducts caused by tamoxifen and toremifene in human microsomal system and lymphocytes in vitro.
    Hemminki K; Widlak P; Hou SM
    Carcinogenesis; 1995 Jul; 16(7):1661-4. PubMed ID: 7614704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microsomal and peroxidase activation of 4-hydroxy-tamoxifen to form DNA adducts: comparison with DNA adducts formed in Sprague-Dawley rats treated with tamoxifen.
    Pathak DN; Pongracz K; Bodell WJ
    Carcinogenesis; 1995 Jan; 16(1):11-5. PubMed ID: 7834794
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparisons of the binding of [14C]radiolabelled tamoxifen or toremifene to rat DNA using accelerator mass spectrometry.
    White IN; Martin EA; Mauthe RJ; Vogel JS; Turteltaub KW; Smith LL
    Chem Biol Interact; 1997 Sep; 106(2):149-60. PubMed ID: 9366900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Major difference in the hepatocarcinogenicity and DNA adduct forming ability between toremifene and tamoxifen in female Crl:CD(BR) rats.
    Hard GC; Iatropoulos MJ; Jordan K; Radi L; Kaltenberg OP; Imondi AR; Williams GM
    Cancer Res; 1993 Oct; 53(19):4534-41. PubMed ID: 8402624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver.
    Montandon F; Williams GM
    Arch Toxicol; 1994; 68(4):272-5. PubMed ID: 8067901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA adduct formation in the livers of female Sprague-Dawley rats treated with toremifene or alpha-hydroxytoremifene.
    Gamboa da Costa G; Pereira PC; Churchwell MI; Beland FA; Marques MM
    Chem Res Toxicol; 2007 Feb; 20(2):300-10. PubMed ID: 17261033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and reactivity of potential toxic metabolites of tamoxifen analogues: droloxifene and toremifene o-quinones.
    Yao D; Zhang F; Yu L; Yang Y; van Breemen RB; Bolton JL
    Chem Res Toxicol; 2001 Dec; 14(12):1643-53. PubMed ID: 11743747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanism of lower genotoxicity of toremifene compared with tamoxifen.
    Shibutani S; Ravindernath A; Terashima I; Suzuki N; Laxmi YR; Kanno Y; Suzuki M; Apak TI; Sheng JJ; Duffel MW
    Cancer Res; 2001 May; 61(10):3925-31. PubMed ID: 11358807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activation of the tamoxifen derivative metabolite E to form DNA adducts: comparison with the adducts formed by microsomal activation of tamoxifen.
    Pongracz K; Pathak DN; Nakamura T; Burlingame AL; Bodell WJ
    Cancer Res; 1995 Jul; 55(14):3012-5. PubMed ID: 7606720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genotoxic effects of the novel mixed antiestrogen FC-1271a in comparison to tamoxifen and toremifene.
    Hellmann-Blumberg U; Taras TL; Wurz GT; DeGregorio MW
    Breast Cancer Res Treat; 2000 Mar; 60(1):63-70. PubMed ID: 10845810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of evidence for tamoxifen- and toremifene-DNA adducts in lymphocytes of treated patients.
    Bartsch H; Phillips DH; Nair J; Hewer A; Meyberg-Solomeyer G; Grischke EM
    Carcinogenesis; 2000 Apr; 21(4):845-7. PubMed ID: 10753226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA adduct formation by tamoxifen with rat and human liver microsomal activation systems.
    Pathak DN; Bodell WJ
    Carcinogenesis; 1994 Mar; 15(3):529-32. PubMed ID: 8118938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA adduction by polychlorinated biphenyls: adducts derived from hepatic microsomal activation and from synthetic metabolites.
    Pereg D; Robertson LW; Gupta RC
    Chem Biol Interact; 2002 Feb; 139(2):129-44. PubMed ID: 11823002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen: evidence by 32P-postlabeling and use of metabolic inhibitors for two distinct pathways leading to mouse hepatic DNA adduct formation and identification of 4-hydroxytamoxifen as a proximate metabolite.
    Randerath K; Moorthy B; Mabon N; Sriram P
    Carcinogenesis; 1994 Oct; 15(10):2087-94. PubMed ID: 7955037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tamoxifen metabolic activation: comparison of DNA adducts formed by microsomal and chemical activation of tamoxifen and 4-hydroxytamoxifen with DNA adducts formed in vivo.
    Moorthy B; Sriram P; Pathak DN; Bodell WJ; Randerath K
    Cancer Res; 1996 Jan; 56(1):53-7. PubMed ID: 8548775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peroxidase activation of tamoxifen and toremifene resulting in DNA damage and covalently bound protein adducts.
    Davies AM; Martin EA; Jones RM; Lim CK; Smith LL; White IN
    Carcinogenesis; 1995 Mar; 16(3):539-45. PubMed ID: 7697811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA damage and altered gene expression of enzymes for metabolism and DNA repair by tamoxifen and toremifene in the female rat liver.
    Hashiba M; Kasahara T; Kim SY; Shibutani S; Degawa M
    Cancer Sci; 2006 Jun; 97(6):468-77. PubMed ID: 16734724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotoxicity studies with the antiestrogen toremifene.
    Williams GM; Ross PM; Jeffrey AM; Karlsson S
    Drug Chem Toxicol; 1998 Nov; 21(4):449-76. PubMed ID: 9839155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hepatic aneuploidy in vivo by tamoxifen, toremifene and idoxifene in female Sprague-Dawley rats.
    Sargent LM; Dragan YP; Sattler C; Bahnub N; Sattler G; Martin P; Cisneros A; Mann J; Thorgeirsson S; Jordan VC; Pitot HC
    Carcinogenesis; 1996 May; 17(5):1051-6. PubMed ID: 8640912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA binding of tamoxifen and its analogues: identification of the tamoxifen-DNA adducts in rat liver.
    Rajaniemi H; Koskinen M; Mäntylä E; Hemminki K
    Toxicol Lett; 1998 Dec; 102-103():453-7. PubMed ID: 10022295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.